As of 2025-06-27, the Fair Value of Acorda Therapeutics Inc (ACOR) is -554.60 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.01 USD, the upside of Acorda Therapeutics Inc is -4,108,248.00%.
With the market price of 0.01 USD and our fair value calculation, Acorda Therapeutics Inc (ACOR) is not a good investment. Investing in ACOR stocks now will result in a potential loss of 4,108,248.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -273.00 | -99.60 | -104.00 | -65.90 | -252.85 | -159.07 |
| YoY growth | -910.09% | 63.52% | -4.42% | 36.63% | -283.69% | -219.61% |
| Market Cap (mil) | 1.82 |
| P/E | |
| Forward P/E |
| EPS | -110.92 |
| Avg earnings growth rate | -219.61% |
| TTM earnings | -252.86 |